Unknown

Dataset Information

Systemic inflammation alters the neuroinflammatory response: a prospective clinical trial in traumatic brain injury.


ABSTRACT:

Background

Neuroinflammation following traumatic brain injury (TBI) has been shown to be associated with secondary injury development; however, how systemic inflammatory mediators affect this is not fully understood. The aim of this study was to see how systemic inflammation affects markers of neuroinflammation, if this inflammatory response had a temporal correlation between compartments and how different compartments differ in cytokine composition.

Methods

TBI patients recruited to a previous randomised controlled trial studying the effects of the drug anakinra (Kineret®), a human recombinant interleukin-1 receptor antagonist (rhIL1ra), were used (n = 10 treatment arm, n = 10 control arm). Cytokine concentrations were measured in arterial and jugular venous samples twice a

SUBMITTER: Lassaren P 

PROVIDER: S-EPMC8464153 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature